Today: 20 May 2026
AUSTRAC hits Airwallex with mandatory AML audit as watchdog tightens fintech checks
23 January 2026
1 min read

AUSTRAC hits Airwallex with mandatory AML audit as watchdog tightens fintech checks

Sydney, January 23, 2026, 11:02 (AEDT)

  • AUSTRAC has mandated Airwallex to bring in an external auditor and deliver the results within 180 days.
  • The regulator raised issues with transaction monitoring, customer verification, and suspicious matter reporting under Australia’s AML/CTF framework.
  • After acquiring South Korea’s Paynuri, Airwallex said it will cooperate as it pushes further into Asia.

Australia’s financial crime watchdog has mandated an external audit of payments company Airwallex, citing worries over its adherence to anti-money laundering and counter-terrorism financing (AML/CTF) regulations. The regulator aims to verify if the fintech’s controls adequately address the risks tied to cross-border fund transfers.

This comes as AUSTRAC intensifies oversight of rapidly expanding payments and remittance firms, where poor controls can enable money laundering. The regulator didn’t allege any criminal wrongdoing by Airwallex, but it has mandated an independent review, paid for by the company, with the audit report expected within 180 days.

Airwallex, which started in Australia and now operates out of San Francisco and Singapore, is stepping up its push into Asia. The company announced it has acquired South Korea’s Paynuri to gain local payments licenses and a foreign-exchange registration. Arnold Chan, APAC general manager, called the deal “a pivotal milestone” in growing Airwallex’s financial platform globally. Airwallex

AUSTRAC issued a written notice alleging that Airwallex may have violated sections of Australia’s AML/CTF Act. The suspected breaches involve ongoing customer due diligence, suspicious matter reporting, and governance requirements. The order, effective from Jan. 1, 2024, directs an auditor to examine transaction monitoring processes, “know your customer” identity checks, and whether Airwallex properly submitted suspicious matter reports—alerts flagged to AUSTRAC for potentially unlawful transactions. AUSTRAC

AUSTRAC’s chief executive Brendan Thomas said the agency brings in external auditors when it detects “serious non-compliance,” urging boards to keep a firm grip on financial crime controls. “AML/CTF is not a back-office function,” he emphasized. AUSTRAC

Airwallex said it would cooperate fully and called its financial crime program robust. An AUSTRAC audit in 2024 was followed by an independent external review in 2025, which validated elements of its program.

Still, an external audit carries follow-up risks for a fast-growing fintech. AUSTRAC can pursue court-ordered civil penalties, hand out infringement notices, or accept enforceable undertakings if a company falls short of its obligations. The watchdog also notes that AML/CTF rules are set to change on March 31, 2026.

AUSTRAC maintains a running list of external auditor notices, highlighting its use of this authority on firms like PayPal Australia, buy-now-pay-later giant Afterpay, Western Union’s Australian remittance unit, and crypto exchange Binance Australia. The latest order targeting Airwallex adds yet another big name to the roster.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900
Previous Story

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week
Next Story

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

Go toTop